Objective To evaluate and compare the effect of interventions for improving adherence to
medications for atherosclerotic cardiovascular disease (ASCVD) secondary prevention …

Cardiovascular disease is the leading cause of death globally. While pharmacological
advancements have improved the morbidity and mortality associated with cardiovascular …

Background Adherence to multiple cardiovascular (CV) medications is a cornerstone of
coronary heart disease (CHD) management and prevention, but it is sub-optimal worldwide …

Background Use of cardiovascular medication has increased over time, especially for
primary and secondary prevention, with polypharmacy common. Methods Review of …

Abstract Purpose of Review The purpose of this review was to synthesize research findings
from recently published randomized controlled trials (RCTs) targeting any phase of …

BACKGROUND Medications for the prevention and treatment of cardiovascular disease
save lives but adherence is often inadequate. The optimal role for physicians in improving …

Although there have been some improvements in adherence rates, it remains a significant
issue. Nonadherence increases both general and cardiac-specific adverse events. Several …

Background: Poor adherence to medications is a significant health care issue, particularly
among cardiovascular patients. A variety of interventions have been tested by researchers in …

Objectives To determine whether adherence interventions should be administered to all
medication takers or targeted to nonadherers. Data sources and study selection Systematic …

Over the past half-century, medical research on cardiovascular disease (CVD) has achieved
a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do …